Xtra Introducing the new PFAT protocol:fat removal for neurological protection

Product catalog summary

Introduction to PFAT Protocol: The PFAT protocol is designed for fat removal to protect neurological functions during surgeries. It addresses the issue of lipid embolism, which can lead to neuropsychological disorders and brain injuries in patients undergoing cardiac and other surgeries.

Research and References: The document references several studies highlighting the risks of cerebral fat embolism and the benefits of fat removal during surgeries. Key studies include those by Dabrowski et al. (2012) on brain damage in cardiac surgery patients and Piuzzi et al. (2014) on paradoxical cerebral fat embolism in hip surgery.

PFAT Protocol Efficacy: The PFAT protocol effectively eliminates fat particles by 99.6% while maintaining an average haematocrit of 50%. It also achieves high elimination rates for albumin (98.8%), free plasma haemoglobin (94.9%), potassium (95.3%), and heparin (99.3%).

Autotransfusion Systems: The Xtra® Autotransfusion system is highlighted as a solution that delivers washed, fresh, and vital autologous RBCs, reducing inflammatory responses and the risk of fat embolism.

Manufacturer Information: The PFAT protocol is developed by Sorin Group, a subsidiary of LivaNova Plc, with manufacturing facilities in Italy and Germany. The quality systems comply with EN ISO 13485:2012 standards.

Conclusion: The PFAT protocol offers a significant advancement in reducing the risk of fat embolism during surgeries, contributing to enhanced patient protection and outcomes.

Catalog excerpts

Xtra Introducing the new PFAT protocol:fat removal for neurological protection-1

Health innovation that matters XTRA® Introducing the new Pfat protocol: fat removal for neurological protection

Open the catalog to page 1

Xtra Introducing the new PFAT protocol:fat removal for neurological protection-2

Contributing to patient protection Neuropsychological disorders and brain injury are a potentially serious problem for patients undergoing cardiac surgery1and other surgical applications2-3. A significant contributor is lipid embolism. ATS solution: The PFAT Protocol Autotransfusion systems deliver washed, fresh and vital autologous RBCs, significantly decreasing the inflammatory response4. The Xtra® Autotransfusion system not only reduces inflammatory risk but also offers the new Pfat protocol, which removes up to 99% of fat particles from intra-operative and postoperative processed blood5,...

Open the catalog to page 2

All LivaNova catalogs and technical brochures

Archived catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.

Brand list